Topics | Preventive Care

mRNA-1083 is an investigational combination vaccine designed to prevent influenza and COVID-19.

The study results also indicate no significant difference of venous thromboembolism risk between individuals with immune-mediated inflammatory diseases and individuals without.

An upcoming large-scale clinical trial of the Glucose Everyday Matters program will evaluate its safety and efficacy in managing type 2 diabetes.

Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.

Compared to the BNT162b2 vaccine, the mRNA-1273 vaccine was associated with a lower risk of adverse events, which investigators speculate was due to interrelated safety and efficacy.

If approved, the V116 vaccine would be the first pneumococcal conjugate vaccine specifically designed for adults.

Further research is necessary in order to investigate whether poor sleep can be a potential risk factor for dementia.

Investigators urge policymakers to establish flexible models that maximize coverage when respiratory syncytial virus activity is high and minimize unnecessary doses when viral activity is low.

Multivitamins were associated with increased cellular oxygen consumption and more optimal blood nutrition biomarkers.

The CDC has recommended a follow-up nucleic acid amplification test to be used for patients clinically suspected to have influenza, despite a negative POC test.